An Evaluation of the Safety and Efficacy of Moxifloxacin Ophthalmic Solution 0.5% ((VIGAMOX®) Versus Ofloxacin Ophthalmic Solution 0.3% in the Treatment of Bacterial Conjunctivitis in Chinese Patients

Clinical trial NCT01573910 · COMPLETED

Trial details

NCT number: NCT01573910
Sponsor: Alcon Research
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bacterial Conjunctivitis

Start date: 2012-05-01
Primary completion: 2014-04-01
Enrollment: 985

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.